721P Ipilimumab and nivolumab compassionate use program in metastatic renal cell carcinoma patients with intermediate or poor IMDC risk score: The large multicenter Italian study
| Autor: | Basso, U., Paolieri, F., Porta, C.G., De Giorgi, U., Bracarda, S., Antonuzzo, L., Atzori, F., Cartenì, G., Procopio, G., Fratino, L., D'Arcangelo, M., Fornarini, G., Zucali, P.A., Cusmai, A., Santoni, M., Baldessari, C., Naglieri, E., Panni, S., Zagonel, V., Tortora, G. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S566-S566 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|